NYSE:OGNPharmaceuticals
Organon (OGN) Stock Stalls As Margin Compression Keeps Value Debate Alive
Organon just posted fresh quarterly numbers and the stock has gone nowhere. The share price sits flat at US$13.55, even as the latest earnings reset the story after a recent quarterly loss. That calm surface hides a real debate. Profitability has been squeezed, with net profit margin over the last year at 4% compared with 11.9% a year earlier, and interest costs are pressing hard on earnings.
For you as an investor, the question is simple: Is the market correctly pricing a balance sheet under...